CD40 ligand - Assessing risk instead of damage?

New England Journal of Medicine

Volumn 348, Issue 12, 2003, Pages 1163-1165

  Freedman, Jane E ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; PADGEM PROTEIN;

ACUTE HEART INFARCTION; CARDIOVASCULAR RISK; EDITORIAL; HEART MUSCLE ISCHEMIA; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOSIS;

ACUTE DISEASE; ANGINA PECTORIS; ANTIBODIES, MONOCLONAL; BIOLOGICAL MARKERS; CD40 LIGAND; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MYOCARDIAL INFARCTION; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; PROGNOSIS; THROMBOSIS;

EID: 0037456735     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMe030012     Document Type: Editorial

References (12)

1. Rinder HM, Bonan JL, Rinder CS, Ault KA, Smith BR. Dynamics of leukocyte-platelet adhesion in whole blood. Blood 1991;78:1730-7.
2. Freedman JE, Loscalzo J. Platelet-monocyte aggregates: bridging thrombosis and inflammation. Circulation 2002;105:2130-2.
3. Furman MI, Barnard MR. Krueger LA, et al. Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. J Am Coll Cardiol 2001;38:1002-6.
4. Huo Y, Schober A, Forlow SB, et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 2003;9:61-7.
5. Henn V, Slupsky JR, Grafe M, et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998;391:591-4.
6. Schonbeck U, Libby P. CD40 signaling and plaque instability. Circ Res 2001;89:1092-103.
7. Andre P, Nannizzi-Alaimo L, Prasad SK, Phillips DR. Plateletderived CD40L: the switch-hitting player of cardiovascular disease. Circulation 2002;106:896-9.
8. Schonbeck U, Varo N, Libby P, Buring J, Ridker PM. Soluble CD40L and cardiovascular risk in women. Circulation 2001;104:2266-8.
9. Heeschen C, Dimmeler S, Hamm CW, et al. Soluble CD40 ligand in acute coronary syndromes. N Engl J Med 2003;348:1104-11.
10. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study. Lancet 1997;349:1429-35. [Erratum, Lancet 1997;350:744.]
11. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-43.
12. Andre P, Prasad KS, Denis CV, et al. CD40L stabilizes arterial thrombi by a beta3 integrin-dependent mechanism. Nat Med 2002;8:247-52.